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To clarify the characteristics of esophageal squamous papillomas (ESPs) in the Japanese
population, we investigated 38 ESPs of 35 Japanese patients from a file with 17,387 upper
gastrointestinal endoscopies in our university hospital. ESPs accounted for 0.20% of the
total number of endoscopies and comprised 21 females and 14 males with an average age
of 59.2 years. More than half of the ESPs (52.6%) were located in the middle esophagus.
The ratio of human papilloma virus (HPV) positive ESPs was 10.5% and all were located in
the middle esophagus of female patients only. HPV-positive ESP cases were younger (46.8
years) than HPV-negative cases (60.8 years). Based on comparison with the reports from
western countries, we attribute the low prevalence in the lower esophagus to the relatively
fewer occurrences of severe reflux esophagitis (RE) due to chronic gastritis with low gastric
acid secretion among Japanese patients.
Key words: squamous papilloma, esophagus, gastroesophageal reflux diseases, reflux esopha-
gitis, human papilloma virus
I. Introduction
Esophageal squamous papilloma (ESP) is a relatively
rare, benign, squamous epithelial tumor [2], which is gener-
ally small, single, round and elevated sessile lesions with
smooth or rough surfaces. Two etiological factors of ESPs
have been posited. One is hyper-regenerative response of the
mucosa to chemical and mechanical irritation such as minor
trauma, chronic food impaction, alcohol consumption,
cigarette smoking, previous gastroesophageal surgery and
gastroesophageal reflux diseases (GERDs) [7, 8, 18, 19,
23]. The mucosal irritant theory is clinically supported by
the high prevalence of ESPs in the lower esophagus, the site
most severely affected by GERDs [7, 8, 18, 23]. The other is
human papilloma virus (HPV) infection [4, 5, 20, 22]. Since
Syrjanen et al. demonstrated the presence of HPV antigens
in ESPs, HPV infection has been considered one of the etio-
logical factors of ESPs [28], although the exact pathogenetic
importance of the HPV is not yet clear.
The prevalence rate of ESPs is estimated at 0.01 to
0.45% according to the results of autopsy and endoscopic
studies [6–8, 15, 17, 23, 26]. ESPs have been thought not to
be endemic [13]. Japanese patients with ESPs have interest-
ing features, because the usual Japanese population does not
have severe reflux esophagitis (RE), which has been consid-
ered an etiological factor of ESPs [7, 8, 16]. So, the geo-
graphic distribution and etiological factors of ESPs in Japan
are likely to be different compared with western countries.
However, no studies have been published in English con-
cerning Japanese patients with ESPs based on a sufficient
number of cases. In this report, we studied 38 ESPs for the
assessment of various clinical, pathological and virological
parameters from the etiological and geographic point of
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II. Methods
Clinical study (patients and samples)
We reviewed a file of 17,387 upper gastrointestinal
endoscopies with biopsies performed consecutively over
a period of 13 years (1989–2001) at Kyoto Prefectural Uni-
versity Hospital to detect patients with ESPs. The data
from the clinical and endoscopic reports that were studied
comprised gender, age, endoscopic appearance, location in
the esophagus, number of tumors and association with
GERD and chronic gastritis. The GERDs included RE, hia-
tal hernia, post-therapeutic state of endoscopic injection
sclerotherapy and post-surgical state of gastrectomy. RE was
endoscopically assessed by experienced endoscopists using
the Los Angeles (LA) classification of esophagitis [3]. The
location of the papillomas was designated as either upper
esophagus (less than 24 cm from the incisors), middle eso-
phagus (between 24 and 32 cm from the incisors), or lower
esophagus (more than 32 cm from the incisors). Chronic
gastritis was diagnosed on the basis of endoscopic findings
and/or biopsy specimens.
Histopathological study
All biopsies were formalin-fixed and paraffin-embed-
ded, and 4 m thick sections were stained with hematoxylin
and eosin (HE) for histopathological studies. The HE-
stained sections of ESPs were investigated for the following
assessments.
1) Histological diagnosis was performed according to
the criteria of the Armed Forces Institute of Pathology
(AFIP) (Fig. 1a) [13].
2) The extent of neutrophil infiltration in the epithelium
of ESPs was determined by using three categories: mild (in-
filtration only of the surface epithelium), moderate (random
infiltration of the epithelium), and marked (random infiltra-
tion of the epithelium and subepithelial stromal tissue) (Fig.
1b).
3) The presence of koilocytosis, which was defined as
squamous cells with irregular nuclei surrounded by a peri-
nuclear cytoplasmic clearing, was also studied (Fig. 1c).
Fig. 1. Histological findings of esophageal squamous papilloma. a) Representative histological features of ESP. The ESP shows a papillary pro-
jection lined with acanthotic squamous epithelium (original magnification: 10). b) Marked neutrophil infiltration in the whole tumor epithe-
lium (original magnification: 25). c) Koilocytosis in ESP is vague compared with dysplasias of uterine cervix (original magnification: 25).Esophageal Squamous Papillomas in Japan 25
Proliferative activity study
Proliferative activity of 28 ESPs from 28 patients was
assessed by using immunohistochemical staining of anti–Ki-
67 antibody (MIB-1). For immunohistochemical staining,
additional sections pretreated by steamer heat (10 mM sodi-
um citrate buffer, 15 min) were stained using a 1:50 dilution
of monoclonal mouse antibody MIB-1 (DAKO, Glostrup,
Denmark) and an EnVision kit (DAKO, Carpinteria, CA,
USA). To evaluate the proliferative activity of ESPs in each
case, we counted about 500 nuclei in the entire layer of the
squamous epithelium. The MIB-1 index in each case was
calculated as the number of positive cells divided by the total
number of cells examined.
Virological study
Thirty-eight formalin–fixed ESPs were examined for
human papilloma virus (HPV) by means of the polymerase
chain reaction (PCR) method using the following procedures
[9, 16, 30].
1) DNA extraction
Three serial 5-m-thick sections from the formalin-
fixed and paraffin-embedded materials of 38 ESPs were
deparaffinized and digested in 50 l of Proteinase K buffer
(50 mM Tris-hydrochloric acid pH 8.3, 1 mM EDTA, 0.5%
Tween 20 with 0.5 mg/ml of Proteinase K) overnight at 5C.
After heat-inactivation (90C, 10 min) of Proteinase K, part
of the supernatant was used for PCR. Twenty-eight non-
neoplastic esophageal epitheliums were also examined as
negative control.
2) PCR analysis
Extracted DNA samples were amplified with a con-
sensus primer pair for HPV gene (TaKaRa Biomedicals,
Osaka, Japan). The consensus primer (forward primer,
5'-TGCTAATTCGGTGCTACCTG-3'; reverse primer, 5'-
GAGCTGTCGCTTAATTGCTC-3') was designed within
the E6 and E7 open reading frame (ORF) for the amplifica-
tion of HPV genotypes 6 and 11 [9]. Amplification reactions
were performed with a heat-stable Thermus aquaticus (Taq)
polymerase (TaKaRa Biomedicals). The template DNA (1
g) was subjected to PCR. The reaction mixture of 50 l
contained 100 mM KCl, 20 mM Tris-HCl pH 8.0, 25 mM
MgCl2, 2.5 mM of each dNTP, 2.5 units of Taq polymerase
and 100 pmol of each consensus primer. The reaction mix-
ture was subjected to 35 cycles of amplification using the
DNA Thermal Cycler (MJ Research, Waltham, MA, USA).
Each cycle consisted of a denaturation step at 94C for 0.5
min, an annealing step at 55C for 1 min, and a chain elon-
gation step at 72C for 1 min.
3) Restriction enzyme analysis of PCR products
To identify the HPV subtypes 6 and 11, the PCR prod-
ucts (2 l) were digested with three units of digestion en-
zyme Afa I (TaKaRa Biomedicals) in 20 l reaction mixture
for 1 hour at 37C. The PCR products cut into 132 and 96 bp
were HPV subtype 6, and those cut into 166 and 62 bps were
HPV subtype 11. The entire PCR and all digested products
(10 l each) were electrophoresed on a composite gel and
photographed with ethidium bromide under UV light.
Statistical analysis
All the differences between grades were assessed with
one or two sample t-tests and Kruskal-Wallis test analyses.
Statistical significance was set at a p-value of less than 0.05.
III. Results
Clinical study
From our hospital file of 17,387 upper gastrointestinal
endoscopies with biopsies, 38 ESPs from 35 patients were
found (prevalence, 0.20%). The patients with ESPs com-
prised 21 females and 14 males with an average age of 59.2
years (25–83 years). All ESPs were endoscopically identi-
fied as small (less than 5 mm), sessile or semi-pedunculated
and whitish polypoid lesions. The location of the ESPs is
shown in Table 1. More than half of the ESPs (52.6%) were
located in the middle esophagus. Most patients had a single
ESP except for three cases with double tumors. Associated
GERDs and chronic gastritis are shown in Table 2. Most of
the patients with ESPs located in the lower esophagus had
GERDs (Table 2). Five (13.2%) of the ESPs were associated
with RE and six (15.8%) with hiatal hernia. All the cases
with RE were classified as grade A, which is the least severe
grade according to the LA classification of esophagitis [3].
Almost all the patients except for younger persons (73.3%)




Histological findings of all ESPs showed they had exo-
phytic, endophytic or spiked features and were lined with
acanthotic stratified squamous epithelium with conserved
normal cellular orientation but without signs of cytological
atypia (Fig. 1a).
2) Epithelial infiltration of neutrophils
The relationship between the degree of neutrophil infil-
tration in the epithelium of ESPs and the tumor location is
noted in Figure 2. ESPs in the lower esophagus were more
markedly inflamed than at any other site of the esophagus
(p0.003, Kruskal-Wallis test). In particular, the five ESPs
associated with RE were all markedly inflamed (Fig. 1b).
Table 1. Distribution of esophageal squamous papillomas
Location of ESPs in 
the esophagus No. of ESPs No. of patients
Upper 9 (23.7%) 8 (22.9%)
Middle 20 (52.6%) 18 (51.4%)
Lower 9 (23.7%) 9 (25.7%)
Total 38 35Takeshita et al. 26
3) Presence of koilocytosis
The epithelium of 23 of the ESPs (61%) showed the
presence of koilocytosis, which was focal compared with
that in the dysplasia of the uterine cervix (Fig. 1c).
Proliferative activity study
The nuclei of the basal, parabasal and sporadically
superficial epithelial cells in the tumors were positive for
MIB-1 (Fig. 3). The ESPs with a high MIB-1 index included
positive cells diffusely distributed in the lower half of the
tumor epithelium. The average number of MIB-1 index in 28
ESPs was 29.21.5 (meanSE). Table 3 shows correlations
between the MIB-1 index and clinicopathological param-
eters. A higher MIB-1 index was observed in the ESPs with
more severe epithelial infiltration of neutrophils (p0.01),
and the tumor MIB-1 index was significantly higher in RE-
affected than in non-affected ESPs (p0.007).
Virological study
Four tumors from four patients (10.5%) were positive
for HPV subtype 6, and no HPV subtype 11 could be iden-
tified (Fig. 4). All non-neoplastic esophageal epitheliums
were negative for HPV. Table 4 shows the correlation of
HPV status with clinicopathological features. All the ESPs
with HPV were single and located in the middle esophagus
and were found more often in relatively young female
patients. While no HPV-positive ESPs were associated
with RE, they showed mild to moderate, but not marked
infiltration of neutrophils. No relation could be established
between MIB-1 and HPV status.
IV. Discussion
The prevalence of ESPs is generally estimated at less
than 0.1% [6–8, 17, 23], except for three Italian studies
(prevalence: 0.12%, 0.45% and 0.35%) [15, 26, 29]. In our
study, the prevalence of ESPs was 0.20%, and the endoscop-
ic analysis from four different hospitals in Japan showed
similar prevalence of ESPs (0.15 to 0.3%, average 0.23%;
unpublished data). These figures are higher than those previ-
ously reported from Europe (Table 5). The majority of the
patients in our study was middle-aged (average 59.2 years),
similar to the age of the populations in previously published
studies. On the other hand, most of reports from western
countries indicated male predominance and high prevalence
in the lower third esophagus [5, 8, 16, 17, 22, 23], whereas,
the male/female ratio was 1/1.57 and more than half of the
ESPs (52.6%) occurred in the middle esophagus in our
study. Mosca et al. also reported the geographic difference
of ESPs from a comparative analysis between Italy and other
western countries based on the literature [15]. Mosca et al.
and our results suggest that there might be considerable
differences in the geographic distribution of ESPs due to
environmental agents functioning as etiological factors.
Chronic esophageal inflammation secondary to GERDs
including RE and hiatal hernia has been suggested as an eti-
ological factor of ESPs [7, 8, 16]. The prevalence of Japa-
nese patients with RE has recently been increasing (about
15%), but severe RE is still not common in Japan [10]. The
patients with chronic gastritis, which has a quite higher prev-
alence in Japan than in western countries, showed reduced
gastric acid secretion [1]. We consider the low prevalence of
ESPs in the lower esophagus to be one of the characteristic
features of Japanese ESP patients and to be due to low prev-
Table 2. Association of gastroesophageal reflux disease with esophageal squamous papillomas
Location of ESPs in the esophagus
Gastroesophageal reflux diseases*
Chronic gastritis
RE HH Post-EIS Post-GR
Upper 0 0 0 0 4
M i d d l e 1010 1 4
Lower 4 6 0 1 4
Total (%)** 5 (13.2%) 6 (15.8%) 1 (2.6%) 1 (2.6%) 22 (73.3%)***
* RE, reflux esophagitis; HH, hiatal hernia; post-EIS, post therapeutic state of endoscopic injection sclerotherapy; post-GR; post-surgical state
of gastrectomy.
** Five of six hiatal hernia were complicated with reflux esophagitis.
*** Thirty cases could be used for the study of chronic gastritis.
Fig. 2. Correlation of tumor location with neutrophil infiltration in
the tumor epithelium (p0.003).Esophageal Squamous Papillomas in Japan 27
alence of severe RE, which is caused by chronic gastritis
with reduced gastric acid secretion. In support of this consid-
eration, the prevalence of severe RE was also low in Italy
[14, 27], and all three studies which showed findings similar
to those of our study, that is, a high prevalence of ESPs,
female dominant sex distribution and high prevalence in the
middle esophagus, were from Italy (Table 5) [15, 26, 29].
Although no pathological studies of the proliferative
activity of ESPs have been reported, the proliferative activi-
ty of ESPs was found to be higher than that of the non-neo-
plastic squamous epithelium (less than 10%) [11]. The find-
ing that the majority of MIB-1 positive nuclei were located
in the basal and parabasal epithelial cells in the tumors sug-
gests that the ESPs continued to preserve the proliferative
orientation of non-neoplastic squamous epithelium. More-
over, the tumor MIB-1 index was significantly associated
Fig. 3. Representative findings of MIB-1 immunohistochemical stains of esophageal squamous papillomas (original magnification: 10). a) A
papilloma case with low MIB-1 index. b) A papilloma with high MIB-1 index.
Table 3. Correlation of the MIB-1 index with clinicopathological
parameters in esophageal squamous papillomas










Moderate 15 27.42.8 0.01
Marked 10 34.62.7
Associated reflux esophagitis
Affected 5 37.22.7 0.007
Non-affected 23 27.21.5
NS: no significance
Fig. 4. Results of PCR analysis to detect human papilloma virus
(HPV) infection in ESPs. a) PCR products using consensus primers-
PCR. Lanes 1-4: PCR products from four cases are HPV-positive.
Lane 5, negative control (no DNA); Lanes 6, positive control (syn-
thetic DNA). b) PCR products digested by restriction enzyme Afa I.
Lanes 1–4 indicate HPV subtype 6.Takeshita et al. 28
with inflammation and affected patients’ proportion of RE.
These results indicate that inflammation due to GERDs has
an important influence on tumor cell proliferation and may
act as an etiological factor of ESPs. As for severely inflamed
ESPs located in the upper to middle esophagus, other envi-
ronmental irritation factors such as smoking, alcohol con-
sumption and GERD-related chronic ear-nose-throat disor-
ders, may play a role in tumorigenesis.
To what extent HPV infection contributes as an etiolog-
ical factor of ESPs is still controversial. While the preva-
lence of HPV-positive ESPs was 10.5% in our study, differ-
ences in detection methods have resulted in variations in
published results ranging from 0% to 64% (Table 5) [4, 6,
12, 15, 16, 20–22, 29]. The PCR method which we used in
this study is more sensitive than in situ hybridization and
immunohistochemical methods. Moreover, the PCR assay
using consensus primers for a portion of the E6–7 open
reading frame is more reliable than the ones using the E1
and L1 region primers, because it is less likely to produce
false-negative results [9, 30]. Although HPV genotypes 6
and 11 are major subtypes in ESPs [4, 12, 20–22], only one
study with a sufficient number of cases and a few case re-
ports have reported the detection of cancer-associated HPV
subtypes [16, 31]. Koilocytosis, which is a histological
finding indicating virus infection, was also found in cases
in which the PCR method could not detect HPV infection.
This seems to indicate that either koilocytosis in some
cases is not related to virus infection [12, 16], or that we
still cannot exclude the infection of other HPV subtypes
[12, 24, 25, 29]. The latter point is supported by the fact
that so far the full genomic sequences of 85 HPV geno-
types have been identified, and that more than 120 putative
novel types have been partially characterized [32].
All the HPV-positive cases were female and their
tumor was located in the middle esophagus, and none of the
female patients with HPV-positive ESPs were associated
with dysplasia or squamous cell carcinoma of the genital
tract. The mean age of the HPV-positive cases was young-
Table 4. Correlation of HPV infection in esophageal squamous
papillomas with clinicopathological parameters
Parameters (%)
HPV infection
Positive (n4) Negative (n34)
Age (average) 46.8 60.8
M : F 0 : 4.0 1 : 1.2
Tumor location
upper 0 (0%) 9 (25.8%)
middle 4 (100%) 16 (45.2%)
lower 0 (0%) 9 (29.0%)
Associated reflux esophagitis 0 (0%) 5 (16.1%)
Neutrophil infiltration
mild 1 (25%) 8 (23%)
moderate 3 (75%) 12 (34%)
marked 0 (0%) 14 (40%)
MIB-1 index (average) 29.4 29.2
Koilocytosis 4 (100%) 19 (55.9%)
Statistical analysis was not done, because the number of HPV-posi-
tive cases was too few.





Mean age & gender 
(M : F)
Dominant 
location Esophagitis HPV Country Author (year)
35 0.20 59.2
14 : 21
Middle  (53%) 13.2% 10.5% Japan Our study
42 0.35 45 y.o.
1 : 1
Middle  (55%) 17% 4.8% Italy Talamini29)  (2000)
35 0.45 45 y.o.
18 : 17
Middle  (46%) 11% NR Italy Sablich26)  (1988)
33 NR 50 y.o.
24 : 9
Lower  (71%) 61% 50% Canada Odze16)  (1993)
28 NR 50 y.o.
1 : 1
Lower  (55%) NR 3.4% Slovenia
Porland
Poljak21)  (1995)
25 NR 57 y.o.
17 : 5
Lower  (64%) 48% NR  (4.3%)6) USA Carr4,5)  (1994)
15 0.08 48 y.o.
11 : 4
Lower  (67%) 33% NR Italy Franzin8)  (1983)
12 0.07 49 y.o.
6 : 6
Lower  (92%) NR 0% Finland Chang6)  (1991)
11 NR 57 y.o.
(NR)
NR NR 64% Germany Lavergne12)  (1999)
9 0.12* 43 y.o.
4 : 5
Middle  (78%) 0% NR Italy Mosca15)  (2001)
60 . 0 4 6 3  y . o .
2 : 4
Lower  (83%) 100% NR Spain Fernandez7)  (1986)
* Nine ESPs from 7,618 upper gastrointestinal endoscopies.
NR; not recorded in detail or not studied.Esophageal Squamous Papillomas in Japan 29
er than that of HPV-negative cases. The past literature also
reported similar results in that the middle esophagus was
the most common location of the tumor of HPV-positive
ESP cases, and that such patients were relatively younger
than HPV-negative ESP cases [16]. Our results and the liter-
ature might indicate that the middle esophagus represents a
favorable environment for HPV infection.
In conclusion, we investigated three aspects of 38 ESPs
in 35 Japanese patients, clinical, histopathological and viro-
logical. From the geographic point of view, there is no En-
glish report studying Japanese ESP patients with comparison
of findings from western countries. We posit that the charac-
teristics of ESPs in Japanese patients are relatively high
prevalence (0.20%), female dominance and high frequency
of location in the middle esophagus. We attribute the domi-
nant middle esophagus distribution (the equivalent of low
prevalence in the lower esophagus) to high prevalence of
chronic gastritis in Japan, which brings in low prevalence of
severe RE. Also similar with previous studies, HPV-positive
ESPs cases showed female predominance, relatively young
age and high prevalence of location in the middle esophagus.
The high prevalence of ESPs seems to indicate that other eti-
ological factors than RE may contribute more to ESP tumor-
igenesis in Japan. This is the first report in English of a study
of Japanese ESP patients based on a sufficient number of
cases to provide meaningful results.
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